Research on Zebrafish Embryos Reveals Origin of the Lymphatic System
|
By LabMedica International staff writers Posted on 03 Jun 2015 |

Image: Zebrafish embryos with fluorescent blood vessels helped solve the mystery regarding the origin of the lymphatic system (Photo courtesy of the Weizmann Institute of Science).
A team of developmental biologists working with a zebrafish embryo model system has located the site of origin of the lymphatic system and identified a gene critical to the differentiation of stem cells into mature lymphatic cells.
Investigators at the Weizmann Institute of Science (Rehovot, Israel) exploited the transparent bodies of zebrafish embryos to document development in real time over a period of several days. By reversing the direction of the video images, they were able to determine that the cells giving rise to lymphatic vessels always originated in a niche of angioblasts localized at the same part of the embryo's major vein.
Zooming in to the molecular level, the investigators identified the Wnt5b protein as a novel lymphatic inductive signal in the zebrafish embryos and further showed that it promoted the "angioblast-to-lymphatic" transition in human embryonic stem cells as well. Wnt5b in humans is encoded by the WNT5B (Wingless-type MMTV integration site family, member 5B) gene. The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis.
Writing in the May 20, 2015, online edition of the journal Nature, the investigators reported that addition of Wnt5b to cultures of human embryonic stem cells induced those cells to differentiate into lymphatic cells—possibly the first time such cells had been grown in a laboratory.
"We started out by imaging zebrafish, and ended up finding a factor that makes it possible to create lymphatic cells," said senior author Dr. Karina Yaniv, assistant professor of biological regulation at the Weizmann Institute of Science. "That is the beauty of research in developmental biology: The embryo holds the answers, and all we have to do is watch and learn."
Related Links:
Weizmann Institute of Science
Investigators at the Weizmann Institute of Science (Rehovot, Israel) exploited the transparent bodies of zebrafish embryos to document development in real time over a period of several days. By reversing the direction of the video images, they were able to determine that the cells giving rise to lymphatic vessels always originated in a niche of angioblasts localized at the same part of the embryo's major vein.
Zooming in to the molecular level, the investigators identified the Wnt5b protein as a novel lymphatic inductive signal in the zebrafish embryos and further showed that it promoted the "angioblast-to-lymphatic" transition in human embryonic stem cells as well. Wnt5b in humans is encoded by the WNT5B (Wingless-type MMTV integration site family, member 5B) gene. The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis.
Writing in the May 20, 2015, online edition of the journal Nature, the investigators reported that addition of Wnt5b to cultures of human embryonic stem cells induced those cells to differentiate into lymphatic cells—possibly the first time such cells had been grown in a laboratory.
"We started out by imaging zebrafish, and ended up finding a factor that makes it possible to create lymphatic cells," said senior author Dr. Karina Yaniv, assistant professor of biological regulation at the Weizmann Institute of Science. "That is the beauty of research in developmental biology: The embryo holds the answers, and all we have to do is watch and learn."
Related Links:
Weizmann Institute of Science
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
Primary central nervous system lymphoma (PCNSL) is typically diagnosed through surgical biopsy, which remains the gold standard but carries substantial risk. Operability depends heavily on tumor location,... Read more
New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers, marked by poor survival rates and limited treatment options, especially in patients who do not respond to standard therapies.... Read moreHematology
view channel
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channelAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read morePathology
view channel
AI Algorithms Improve Genetic Mutation Detection in Cancer Diagnostics
Accurately identifying genetic mutations is central to cancer diagnostics and genomic research, but current methods struggle with complex sequencing data and limited clinical samples. Tumor analysis often... Read more
Skin Biopsy Offers New Diagnostic Method for Neurodegenerative Diseases
Transthyretin amyloidosis (ATTR) is a rare, progressive, and highly aggressive disease caused by the misfolding of a specific protein that accumulates as toxic amyloid filaments in multiple organs.... Read moreTechnology
view channelAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







